Menu
GeneBe

chr3-54122720-G-C

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_018398.3(CACNA2D3):ā€‹c.7G>Cā€‹(p.Gly3Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000383 in 1,195,872 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.00018 ( 0 hom., cov: 29)
Exomes š‘“: 0.00041 ( 0 hom. )

Consequence

CACNA2D3
NM_018398.3 missense

Scores

2
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.873
Variant links:
Genes affected
CACNA2D3 (HGNC:15460): (calcium voltage-gated channel auxiliary subunit alpha2delta 3) This gene encodes a member of the alpha-2/delta subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. Various versions of each of these subunits exist, either expressed from similar genes or the result of alternative splicing. Research on a highly similar protein in rabbit suggests the protein described in this record is cleaved into alpha-2 and delta subunits. Alternate transcriptional splice variants of this gene have been observed but have not been thoroughly characterized. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0411793).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CACNA2D3NM_018398.3 linkuse as main transcriptc.7G>C p.Gly3Arg missense_variant 1/38 ENST00000474759.6
LOC124909381XR_007095914.1 linkuse as main transcriptn.386+337C>G intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CACNA2D3ENST00000474759.6 linkuse as main transcriptc.7G>C p.Gly3Arg missense_variant 1/381 NM_018398.3 P1Q8IZS8-1
ENST00000666932.1 linkuse as main transcriptn.1187+337C>G intron_variant, non_coding_transcript_variant

Frequencies

GnomAD3 genomes
AF:
0.000180
AC:
27
AN:
149936
Hom.:
0
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.000122
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000133
Gnomad ASJ
AF:
0.000290
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000416
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000252
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.000412
AC:
431
AN:
1045830
Hom.:
0
Cov.:
30
AF XY:
0.000411
AC XY:
203
AN XY:
493490
show subpopulations
Gnomad4 AFR exome
AF:
0.0000465
Gnomad4 AMR exome
AF:
0.000419
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000104
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000464
Gnomad4 OTH exome
AF:
0.000220
GnomAD4 genome
AF:
0.000180
AC:
27
AN:
150042
Hom.:
0
Cov.:
29
AF XY:
0.000218
AC XY:
16
AN XY:
73314
show subpopulations
Gnomad4 AFR
AF:
0.000122
Gnomad4 AMR
AF:
0.000132
Gnomad4 ASJ
AF:
0.000290
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000416
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000252
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000208
Hom.:
0
Bravo
AF:
0.000185

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 08, 2023The c.7G>C (p.G3R) alteration is located in exon 1 (coding exon 1) of the CACNA2D3 gene. This alteration results from a G to C substitution at nucleotide position 7, causing the glycine (G) at amino acid position 3 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.25
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.71
CADD
Benign
12
DANN
Benign
0.97
DEOGEN2
Benign
0.056
T;T;T
Eigen
Benign
-1.0
Eigen_PC
Benign
-0.92
FATHMM_MKL
Benign
0.19
N
M_CAP
Pathogenic
0.47
D
MetaRNN
Benign
0.041
T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
0.0
N;N;N
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Pathogenic
0.83
D
PROVEAN
Benign
0.30
N;N;N
REVEL
Benign
0.056
Sift
Benign
0.52
T;T;T
Sift4G
Benign
0.082
T;T;T
Polyphen
0.0
B;B;B
Vest4
0.10
MutPred
0.24
Gain of MoRF binding (P = 0.0122);Gain of MoRF binding (P = 0.0122);Gain of MoRF binding (P = 0.0122);
MVP
0.043
MPC
0.31
ClinPred
0.20
T
GERP RS
-2.9
Varity_R
0.047
gMVP
0.32

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs531852353; hg19: chr3-54156747; API